Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
M Stoll, … , R Metzger, T Unger
M Stoll, … , R Metzger, T Unger
Published February 1, 1995
Citation Information: J Clin Invest. 1995;95(2):651-657. https://doi.org/10.1172/JCI117710.
View: Text | PDF
Research Article

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

  • Text
  • PDF
Abstract

Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle cells and fibroblasts but little is known about its influence on growth in endothelial cells. We studied the effects of ANG II on endothelial growth and the role of the angiotensin receptor subtypes involved. Proliferation of rat coronary endothelial cells (CEC) and rat vascular smooth muscle cells (VSMC) was determined by [3H]thymidine incorporation, the MTT-test and by directly counting cells in a coulter counter. Angiotensin AT1- and AT2-receptors were demonstrated by binding studies and by the presence of their respective mRNA through reverse transcription polymerase chain reaction (RT-PCR). In contrast to VSMC, which in culture only express the AT1-receptor, CEC express both, AT1- and AT2-receptors simultaneously up to the third passage. Whereas ANG II stimulated growth of quiescent VSMC, an effect abolished by pretreatment with the AT1-receptor antagonist, losartan, ANG II did not induce proliferation in quiescent CEC. However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation. This effect was reversed by additional pretreatment with losartan. ANG II significantly inhibited the proliferation of bFGF-stimulated CEC in a dose-dependent manner by maximally 50%. This effect was prevented by PD 123177 while losartan was ineffective. The AT2-receptor agonist, CGP 42112, mimicked the antiproliferative actions of ANG II, confirming the specificity of the effect. Our results show that the growth modulating actions of ANG II depend on the type of angiotensin receptor present on a given cell. In coronary endothelial cells, the antiproliferative actions of the AT2-receptor offset the growth promoting effects mediated by the AT1-receptor.

Authors

M Stoll, U M Steckelings, M Paul, S P Bottari, R Metzger, T Unger

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Total
Citations: 1 5 2 4 4 2 5 3 5 3 12 4 9 15 16 25 16 18 16 16 29 28 30 39 54 50 69 61 54 45 11 651
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2003 (30)

Title and authors Publication Year
Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model
N Hashimoto, Y Maeshima, M Satoh, M Odawara, H Sugiyama, N Kashihara, H Matsubara, Y Yamasaki, H Makino
American journal of physiology. Renal physiology 2003
Angiotensin AT2receptors: cardiovascular hope or hype?
RE Widdop, ES Jones, RE Hannan, TA Gaspari
British Journal of Pharmacology 2003
RAS and connective tissue in the heart
Y Sun, KT Weber
The International Journal of Biochemistry & Cell Biology 2003
Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders
GH Goossens, EE Blaak, MA van Baak
Obesity Reviews 2003
Can Angiotensin-converting Enzyme Inhibitors Reverse Atherosclerosis?
JP Higgins
Southern Medical Journal 2003
Angiotensin II AT2 receptor subtype
M Volpe, B Musumeci, PD Paolis, C Savoia, A Morganti
Journal of Hypertension 2003
Retinal Angiogenesis Is Mediated by an Interaction between the Angiotensin Type 2 Receptor, VEGF, and Angiopoietin
S Sarlos, B Rizkalla, CJ Moravski, Z Cao, ME Cooper, JL Wilkinson-Berka
The American Journal of Pathology 2003
Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction
AM Salam
Expert Opinion on Investigational Drugs 2003
Effects of KD3-671, an Angiotensin II Type 1 Receptor Antagonist, on Anti-Thy-1 Nephritis in Rats
T Nagamatsu, T Oka, T Nagao, Y Suzuki
Biological & Pharmaceutical Bulletin 2003
Effects of Angiotensin II on Nitric Oxide Generation in Proliferating and Quiescent Rat Coronary Microvascular Endothelial Cells
U BAYRAKTUTAN, S ÜLKER
Hypertension Research 2003
Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats
C Pees, T Unger, P Gohlke
The International Journal of Biochemistry & Cell Biology 2003
Angiotensin II and its receptors in human endocardial endothelial cells: role in modulating intracellular calcium
D Jacques, NA Malak, S Sader, C Perreault
Canadian Journal of Physiology and Pharmacology 2003
Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells
Y Zhao, T Biermann, C Luther, T Unger, J Culman, P Gohlke
Journal of Neurochemistry 2003
Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells
U Bayraktutan
Journal of Hypertension 2003
AT1 and AT2 receptors in human glomerular endothelial cells at different passages
B Cresci, S Giannini, L Pala, C Mavilia, C Manuelli, P Cappugi, E Magg, CM Rotella
Microvascular Research 2003
Trophic and steroidogenic effects of water deprivation on the adrenal gland of the adult female rat
D Chatelain, V Montel, A Dickes-Coopman, A Chatelain, S Deloof
Regulatory Peptides 2003
Characterization of angiotensin II–receptor subtypes in podocytes
L Wang, PJ Flannery, RF Spurney
Journal of Laboratory and Clinical Medicine 2003
The regulation of HGF and TGF-β by an angiotensin II type 1 receptor antagonist in hepatic ischemia-reperfusion injury
J Araya, T Tsuruma, K Hirata, A Yagihashi, M Meguro, M Kawakami, Y Yanai, N Watanabe
Transplantation Proceedings 2003
Effect of Angiotensin II lype 2 Receptor Blockade on Activation of Mitogen-Activated Protein Kinases after Ischemia-Reperfusion in Isolated Working Rat Hearts
D Kumar, V Menon, WR Ford, AS Clanachan, BI Jugdutt
Journal of cardiovascular pharmacology and therapeutics 2003
Expression of angiotensin type II receptor downregulates Cdk4 synthesis and inhibits cell-cycle progression
B Gingras, G Rodier, E Giasson, P Coulombe, C Chassagne, S Meloche
Oncogene 2003
Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice
X Yan, RL Price, M Nakayama, K Ito, AJ Schuldt, WJ Manning, A Sanbe, TK Borg, J Robbins, BH Lorell
American journal of physiology. Heart and circulatory physiology 2003
Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage
V Grishko, V Pastukh, V Solodushko, M Gillespie, J Azuma, S Schaffer
American journal of physiology. Heart and circulatory physiology 2003
A role for angiotensin II AT 1 receptors in ureteric bud cell branching
IV Iosipiv, M Schroeder
American journal of physiology. Renal physiology 2003
Hypoxia and high glucose upregulate AT 1 receptor expression and potentiate ANG II-induced proliferation in VSM cells
CP Sodhi, YS Kanwar, A Sahai
American journal of physiology. Heart and circulatory physiology 2003
Angiotensin II mediates LDL-induced superoxide generation in mesangial cells
SY Park, CY Song, BC Kim, HK Hong, HS Lee
American journal of physiology. Renal physiology 2003
An AT1-Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor Protect Against Hypoxia-Induced Apoptosis in Human Aortic Endothelial Cells Through Upregulation of Endothelial Cell Nitric Oxide Synthase Activity:
N Matsumoto, H Manabe, J Ochiai, N Fujita, T Takagi, M Uemura, Y Naito, N Yoshida, S Oka, T Yoshikawa
Shock 2003
Differential regulation of in vivo angiogenesis by angiotensin II receptors
T Walther, A Menrad, HD Orzechowski, G Siemeister, M Paul, M Schirner
The FASEB Journal 2003
Cardiac Angiotensin II Type 2 Receptor Activates the Kinin/NO System and Inhibits Fibrosis
S Kurisu, R Ozono, T Oshima, M Kambe, T Ishida, H Sugino, H Matsuura, K Chayama, Y Teranishi, O Iba, K Amano, H Matsubara
Hypertension 2003
Cardiac Remodeling and Failure
PK Singal, IM Dixon, LA Kirshenbaum, NS Dhalla
2003
Increased Renal Vascular Endothelial Growth Factor and Angiopoietins by Angiotensin II Infusion Is Mediated by Both AT 1 and AT 2 Receptors
B Rizkalla, JM Forbes, ME Cooper, Z Cao
Journal of the American Society of Nephrology : JASN 2003

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts